FIELD: medicine, in particular composition or combination of topiramate and erythropoietin topiramate and erythropoietin and application thereof for neurite growth stimulation.
SUBSTANCE: claimed composition contains 1 fM of topiramate and 1 pM of erythropoietin or 10 fM of topiramate in combination with 1 pM or 100 pM of erythropoietin and pharmaceutically acceptable carrier.
EFFECT: synergistically enhanced neurite growth stimulation.
3 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VERSIONS OF ERYTHROPOETINE | 2006 |
|
RU2430162C2 |
| COMPOUNDS AND PHARMACEUTIC COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES | 2012 |
|
RU2569302C2 |
| AGONISTS OF NEUROTROPHIN RECEPTORS AND THEIR USE AS MEDICAMENTS | 2011 |
|
RU2606622C2 |
| APPLICATION OF K-252A DERIVATIVES TO TREAT DISORDERS OF PERIPHERAL OR CENTRAL NERVOUS SYSTEMS AND EXCESSIVE CYTOKINE OUTPUT | 1997 |
|
RU2183959C2 |
| APPLICATION OF TOPIRAMATE OR ITS DERIVATIVES TO OBTAIN MEDICINAL PREPARATION FOR TREATING MANIC-DEPRESSIVE BIPOLAR DISORDERS | 1997 |
|
RU2185824C2 |
| USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) | 2017 |
|
RU2742828C2 |
| HERBS-CONTAINING COMPOSITION | 2013 |
|
RU2642591C2 |
| PROTOFIBRIL-BINDING ANTIBODIES AND USE THEREOF IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR PARKINSON'S DISEASE, DEMENTIA WITH LEWY BODIES AND OTHER ALPHA-SYNUCLEINOPATHIES | 2011 |
|
RU2555526C2 |
| DERIVATIVES WITH ANTICONVULSANT ACTIVITY APPROPRIATE FOR TREATING NEUROPATHIC PAIN | 1997 |
|
RU2175868C2 |
| ETHYLEICOSAPENTAENOIC ACID OF HIGH PURITY DEGREE AND OTHER DERIVATIVES OF EICOSAPENTAENOIC ACID FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS | 2000 |
|
RU2260423C2 |
